The somatic silence or down-regulation of ASS1 expression are very common in various of tumors, including melanoma, prostate cancer, breast cancer, bladder cancer, mesothelioma, pancreatic cancer, nasopharyngeal carcinoma, osteosarcomas, and myxofibrosarcomas3–6. This evidence concerns the gene ASS1 and familial pancreatic carcinoma.